Hundreds of millions of people around the world choose to smoke, despite the well-known health risks. We are passionate about our tobacco business and pride ourselves on offering consumers a choice of high-quality products and market-leading innovations that meet their needs.

We are also extending that choice by developing innovative tobacco and nicotine products that provide consumers with a choice of potentially less risky alternatives to smoking regular cigarettes. We call them Next Generation Products (NGPs) and they include Vapour Products like e-cigarettes, Tobacco Heating Products and nicotine products that are licensed as medicines.

We have invested more than £500 million over five years in developing a world-leading portfolio of products in the NGP category – not just because they are an exciting new opportunity for us, but also because there are clear benefits for society in helping reduce smoking-related disease.

We believe we are best placed to do this because we understand consumer needs, we have world-class R&D capabilities and robust product and quality standards. We also have global reach and a clear commitment to market our products responsibly.
Investment in Next Generation Products
“The hazard to health arising from long-term vapour inhalation from the e-cigarettes available today is unlikely to exceed 5% of the harm from smoking tobacco.”

Nicotine without smoke: Tobacco harm reduction - a report by the Tobacco Advisory Group of the Royal College of Physicians, April 2016
Next Generation Products
invested over five years in developing a world-leading portfolio of Next Generation Products
The strength of our commitment to Next Generation Products can best be demonstrated through the progress we are making.

In 2013, we were the first international tobacco company to launch an e-cigarette brand – Vype – in the UK. Since then, we have used our experience and insights to develop the range and to launch in other markets, including Germany, France, Colombia, Italy and Poland.

We brought out our first Tobacco Heating Product, iFuse, in Romania in 2015. This product heats tobacco to vaporise the nicotine into an inhalable aerosol that delivers a real tobacco taste and flavour.

We were the first ever tobacco company to have a nicotine inhalation product – Voke – licensed as a medicine. We are now working on the large-scale manufacturing and commercialisation of this new product.
Discover more about NGPs at